AVVM

The gap

In the realm of veterinary vaccines, there exist several discernible gaps that impede the advancement of vaccine development and distribution.

1

Lack of accessible and cost-effective vaccine development platforms

2

Low penetration rates of existing vaccines

3

Lack of understanding of protective immune responses for efficacy assessment

4

Low efficacy and poor vaccine thermostability

5

Absence of DIVA* marker vaccines for transboundary diseases

6

Funding and unclear regulations limit Risk Group 3/4 vaccine development

7

Limited adoption of low-risk modern vaccine development platforms

8

Limited public-private partnerships for manufacturing and technology transfer

*DIVA - Differentiating Infected from Vaccinated Animals

Scroll to Top